Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection

被引:1329
作者
Starley, Brad Q. [1 ]
Calcagno, Christopher J.
Harrison, Stephen A. [1 ]
机构
[1] Brooke Army Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Ft Sam Houston, TX 78234 USA
关键词
CHRONIC HEPATITIS-C; TERM-FOLLOW-UP; NATURAL-HISTORY; CRYPTOGENIC CIRRHOSIS; RISK-FACTORS; METABOLIC SYNDROME; GENERAL-POPULATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; UNITED-STATES;
D O I
10.1002/hep.23594
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Hepatocellular carcinoma (HCC) is a common and deadly malignancy that is increasing in incidence in developed countries. The emergence of hepatitis C virus (HCV) accounts for about half of this increase in HCC, although the etiology of HCC in 15%-50% of new HCC cases remains unclear. The most common form of chronic liver disease in developed countries is nonalcoholic fatty liver disease (NAFLD), which encompasses a broad spectrum of histopathology. The prevalence of NAFLD, including the more aggressive nonalcoholic steatohepatitis (NASH), is increasing with the growing epidemics of diabetes and obesity. NASH can progress to cirrhosis and its related complications. Growing evidence suggests that NASH accounts for a large proportion of idiopathic or cryptogenic cirrhosis, which is associated with the typical risk factors for NASH. HCC is a rare, although important complication of NAFLD. Diabetes and obesity have been established as independent risk factors for the development of HCC. New evidence also suggests that hepatic iron deposition increases the risk of HCC in NASH-derived cirrhosis. Multiple case reports and case reviews of HCC in the setting of NASH support the associations of diabetes and obesity with the risk of HCC, as well as suggest age and advanced fibrosis as significant risks. Insulin resistance and its subsequent inflammatory cascade that is associated with the development of NASH appear to play a significant role in the carcinogenesis of HCC. The complications of NASH, including cirrhosis and HCC, are expected to increase with the growing epidemic of diabetes and obesity. (HEPATOLOGY 2010;51:1820-1832)
引用
收藏
页码:1820 / 1832
页数:13
相关论文
共 133 条
[21]
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[22]
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].
Calle, EE ;
Kaaks, R .
NATURE REVIEWS CANCER, 2004, 4 (08) :579-591
[23]
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients? [J].
Chagas, A. L. ;
Kikuchi, L. O. O. ;
Oliveira, C. P. M. S. ;
Vezozzo, D. C. P. ;
Mello, E. S. ;
Oliveira, A. C. ;
Cella, L. C. ;
Herman, P. ;
Bachella, T. ;
Caldwell, S. H. ;
Alves, V. A. F. ;
Carrilho, F. J. .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (10) :958-962
[24]
Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer [J].
Chang, Qingshan ;
Zhang, Yadong ;
Beezhold, Kevin J. ;
Bhatia, Deepak ;
Zhao, Hongwen ;
Chen, Jianguo ;
Castranova, Vince ;
Shi, Xianglin ;
Chen, Fei .
JOURNAL OF HEPATOLOGY, 2009, 50 (02) :323-333
[25]
JNK1, a potential therapeutic target for hepatocellular carcinoma [J].
Chen, Fei ;
Beezhold, Kevin ;
Castranova, Vince .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2009, 1796 (02) :242-251
[26]
Beyond apoptosis of JNK1 in liver cancer [J].
Chen, Fei ;
Castranova, Vince .
CELL CYCLE, 2009, 8 (08) :1145-1147
[27]
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome [J].
Chitturi, S ;
Abeygunasekera, S ;
Farrell, GC ;
Holmes-Walker, J ;
Hui, JM ;
Fung, C ;
Karim, R ;
Lin, R ;
Samarasinghe, D ;
Liddle, C ;
Weltman, M ;
George, J .
HEPATOLOGY, 2002, 35 (02) :373-379
[28]
Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI 10.1111/j.1572-0241.2003.07486.x
[29]
Non-alcoholic fatty liver: another feature of the metabolic syndrome? [J].
Cortez-Pinto, H ;
Camilo, ME ;
Baptista, A ;
De Oliveira, AG ;
De Moura, MC .
CLINICAL NUTRITION, 1999, 18 (06) :353-358
[30]
Nonalcoholic steatohepatitis and hepatocellular carcinoma:: Natural history? [J].
Cotrim, HP ;
Paraná, R ;
Braga, E ;
Lyra, L .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10) :3018-3019